Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,133.10 | 6.20 | 0.08% |
| CAC 40 | 7,807.00 | 69.36 | -0.88% |
| DAX 40 | 22,186.10 | 353.88 | -1.57% |
| Dow JONES (US) | 41,989.96 | 11.80 | -0.03% |
| FTSE 100 | 8,577.22 | 57.58 | -0.67% |
| HKSE | 23,202.53 | 4.31 | -0.02% |
| NASDAQ | 17,449.89 | 150.60 | 0.87% |
| Nikkei 225 | 35,725.87 | 101.39 | 0.28% |
| NZX 50 Index | 12,320.19 | 7.59 | 0.06% |
| S&P 500 | 5,633.07 | 0.00 | 0.00% |
| S&P/ASX 200 | 7,934.50 | 9.30 | 0.12% |
| SSE Composite Index | 3,350.13 | 1.69 | 0.05% |